• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

B. Braun infusion pump battery recall is Class I after one reported death

November 17, 2023 By Sean Whooley

B. Braun Infusomat Space large-volume infusion pump
The Infusomat Space large-volume pump. [Image from B. Braun]
The FDA labeled a recall of B. Braun Medical infusion pump battery packs Class I, the most serious kind.

B. Braun’s recall is a correction, not a product removal, affecting the battery pack for its Infusomat Space large-volume pump. It affects both wireless and non-wireless batteries, model numbers 8713051U and 8713052U.

According to an FDA notice, the company recalled the infusion pump system due to faulty occlusion alarms. On certain models, an occlusion alarm may sound when no occlusion exists, causing the pump to stop the delivery of medications. That includes high-risk medications like vasopressors.

Interruption to high-risk medication delivery could lead to hemodynamic instability requiring medical intervention to prevent impairment to body structures or body functions. In some cases, this could lead to life-threatening circumstances or death.

B. Braun reported 51 complaints, one injury and one death related to this recall.

The recall reaches 10,655 devices in the U.S., distributed between Oct. 26, 2022, and July 17, 2023. The firm initiated the recall on Sept. 21, 2023.

B. Braun told customers to move the device to areas for only low-risk medication delivery and cease use for high-risk medications. They should ensure the availability of a second pump for high-risk medication administration.

The company also plans to reach out to customers and dispatch technicians to replace occlusion pressure sensors with qualified sensors. B. Braun plans for scheduled services to update the impacted devices.

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: B. Braun, B. Braun Medical, FDA

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS